Skip to content

A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial

Financial Compass: A Pilot Feasibility Study of a Novel Intervention to Identify and Address Financial Hardship Among Cancer Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06896695
Enrollment
50
Registered
2025-03-26
Start date
2025-09-23
Completion date
2027-02-25
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Carcinoma

Brief summary

This clinical trial compares the effect a financial intervention, called Financial Compass, to usual care in identifying and addressing financial hardship in patients with head and neck cancer. Previous research has shown that head and neck cancer patients experiencing financial hardship have decreased overall and cancer specific survival. Using a financial intervention, Financial Compass, may be more effective than usual care in identifying and addressing financial hardship in patients with head and neck cancer.

Detailed description

PRIMARY OBJECTIVES: I. Apply community-engaged intervention mapping to tailor the Financial Compass intervention to address the needs and experiences of head and neck cancer patients. (Aim 1) II. Conduct a pilot randomized control trial of Financial Compass to assess feasibility, acceptability and preliminary efficacy among head and neck cancer patients. (Aim 2) OUTLINE: AIM 1: Participants take part in a community advisory board and/or a health care delivery advisory board on study to discuss, develop and refine the Financial Compass intervention. AIM 2: Screening questionnaire to identify financial concerns. Subjects will be randomized to : GROUP I: Patients receive the Financial Compass intervention on study including a patient needs assessment, a tailored care pathway and weekly individualized navigation and support to access resources. GROUP II: Patients receive usual care on study including medical consultations and supportive care. After completion of study intervention, patients are followed up at week 12.

Interventions

OTHERBest Practice

Receive usual care

OTHERDiscussion

Ancillary studies

Receive the Financial Compass intervention

OTHERSurvey Administration

Ancillary studies

Sponsors

Roswell Park Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* They have been diagnosed with head and neck cancer * Screen positive for financial hardship on the validated Comprehensive Score for Financial Toxicity (COST) measure * Are able to participate in English or Spanish

Exclusion criteria

* Adults unable to complete the process of informed consent * Adults whose primary language is not English or Spanish * Individuals who are not yet adults (i.e., infants, children, teenagers) * Unwilling or unable to follow protocol requirements

Design outcomes

Primary

MeasureTime frameDescription
Development of the Financial Compass intervention (Aim 1)Up to 2 yearsWill use stage 1A of the National Institutes of Health Stage Model to further develop the Financial Compass intervention. Will use data from in-depth interviews and collaborative engagement of advisory boards to refine the final Financial Compass intervention package. Will complete the Financial Compass intervention package. Will use the Person, Extended Family, Neighborhood (PEN)-3 model to guide integration of stakeholder feedback into the final Financial Compass intervention package. Will prepare summaries of key findings from the in-depth interviews to review with advisory board members. Themes in advisory board member feedback will be categorized using the main constructs of PEN-3 model in a 3 x 3 table, including (1) perceptions, (2) enablers, and (3) nurturers.
Feasibility of the Financial Compass intervention (Aim 2)Up to 12 weeksWill assess feasibility of the Financial Compass intervention among head and neck cancer patients. Will examine feasibility through demand (study enrollment rates, reasons for refusal), practicality (retention rates, engagement with intervention sessions/materials, reasons for study drop out), and acceptability (participant satisfaction with intervention materials and content). To assess acceptability, will administer the Acceptability of Intervention Measure (4 items), Intervention Appropriateness Measure (4 items) and Feasibility of Intervention Measure (4 items). The measures use a 5-point Likert scale where 1 = completely disagree and 5 = completely agree and have demonstrated strong psychometric properties. In the Financial Compass group, the measures will be summarized using the appropriate descriptive statistics, with estimates of enrollment and retention rates obtained with 90% confidence intervals.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORElizabeth Bouchard

Roswell Park Cancer Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026